BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29180209)

  • 21. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
    Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway.
    Chen W; Lin YJ; Zhou XY; Chen H; Jin Y
    Can J Physiol Pharmacol; 2016 Jan; 94(1):28-34. PubMed ID: 26394869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury.
    Pan CW; Zhou GY; Chen WL; Zhuge L; Jin LX; Zheng Y; Lin W; Pan ZZ
    Int Immunopharmacol; 2015 May; 26(1):80-5. PubMed ID: 25797347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase inhibitors protect D-galactosamine/lipopolysaccharide induced acute hepatic injury in experimental mice model.
    Liong EC; Xiao J; Lau TY; Nanji AA; Tipoe GL
    Food Chem Toxicol; 2012 Mar; 50(3-4):861-6. PubMed ID: 22107987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
    Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
    Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ.
    Tian Q; Wang G; Zhang Y; Zhang F; Yang L; Liu Z; Shen Z
    J Pharmacol Sci; 2019 Jul; 140(3):218-222. PubMed ID: 31473044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice.
    Pu Y; Yang Z; Mo X
    Biomed Res Int; 2021; 2021():2252705. PubMed ID: 34368345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].
    Wu Y; Liang L; Shi G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1009-12. PubMed ID: 25270198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
    Zhang Z; Tian L; Jiang K
    Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
    Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
    Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
    Gong X; Zhang L; Jiang R; Wang CD; Yin XR; Wan JY
    J Appl Toxicol; 2014 Mar; 34(3):265-71. PubMed ID: 23620140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
    Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Inflammatory Activities and Liver Protection of Alisol F and 25-Anhydroalisol F through the Inhibition of MAPK, STAT3, and NF-κB Activation In Vitro and In Vivo.
    Bi X; Wang P; Ma Q; Han L; Wang X; Mu Y; Guan P; Qu X; Wang Z; Huang X
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28594379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysine specific demethylase 1 inhibitor alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury.
    Wang X; Sun Y; Fu Y; Wu H; Chen Y; Ye Y; Zhou Q; He L; Zhou E; Wang J; Yang Z
    Eur J Pharmacol; 2022 Oct; 932():175227. PubMed ID: 36007605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
    Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
    Front Immunol; 2020; 11():285. PubMed ID: 32158448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide/D-galactosamine-induced acute liver injury could be attenuated by dopamine receptor agonist rotigotine via regulating NF-κB signaling pathway.
    Yue S; Wang T; Yang Y; Fan Y; Zhou L; Li M; Fu F
    Int Immunopharmacol; 2021 Jul; 96():107798. PubMed ID: 34162160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pterostilbene Exerts Hepatoprotective Effects through Ameliorating LPS/D-Gal-Induced Acute Liver Injury in Mice.
    Liu Z; Wang J; Zhang Y; Wu D; Li S; Jiang A; Du C; Xie G
    Inflammation; 2021 Apr; 44(2):526-535. PubMed ID: 33006074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.